Related Experiment Video

Updated: Jul 5, 2026

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
08:23

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds

Published on: February 16, 2022

Depression and cardiovascular disease: role of nitric oxide

Vivian Liane M Pinto1, Tatiana M C Brunini, Marcos R Ferraz

  • 1Departamento de Farmacologia e Psicobiologia, Universidade do Estado do Rio de Janeiro Rio de Janeiro, 20551-030, Brazil.

Cardiovascular & Hematological Agents in Medicinal Chemistry
|May 14, 2008
PubMed

Insights

Depression increases cardiovascular disease risk through various physiological changes. Impairment in the L-arginine-nitric oxide pathway may link depression and cardiovascular issues, suggesting new therapeutic targets.

Area of Science:

  • Cardiovascular Science
  • Neuroscience
  • Public Health

Background:

  • Depression is a significant public health issue and a recognized risk factor for coronary artery disease (CAD).
  • The precise mechanisms linking depression and CAD are not fully understood.
  • Depression can lead to metabolic abnormalities, inflammation, and endothelial dysfunction, contributing to cardiovascular events.

Purpose of the Study:

  • To elucidate the mechanisms underlying the relationship between depression and cardiovascular disease.
  • To explore the role of the L-arginine-nitric oxide pathway in the interplay between depression and CAD.
  • To identify potential new therapeutic interventions for comorbid depression and cardiovascular conditions.

Main Methods:

  • Review of existing literature on depression, cardiovascular disease, and the L-arginine-nitric oxide pathway.
  • Analysis of physiological pathways affected by depression, including autonomic and hormonal homeostasis.
  • Examination of the synthesis and function of nitric oxide (NO) and its relation to L-arginine.

Main Results:

  • Depression adversely impacts homeostasis, leading to conditions that promote atherothrombosis.
  • The L-arginine-nitric oxide pathway appears to be impaired in patients with depression.
  • Nitric oxide plays crucial roles in vasodilation, neurotransmission, and inhibiting platelet aggregation.

Conclusions:

  • Understanding the L-arginine-nitric oxide pathway's role is key to comprehending depression as a cardiovascular risk factor.
  • Dysfunction in the L-arginine-nitric oxide pathway may represent a critical link between depression and cardiovascular disease.
  • Further research into this pathway could lead to novel therapeutic strategies for managing both conditions.

More Related Videos

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries08:58

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...